Rhythm Pharmaceuticals, Inc. RYTM Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s net change in cash?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported net change in cash of $7.92M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s net change in cash decreased by 53.3% year-over-year, from $16.96M to $7.92M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s net change in cash?
- Over 2 years (2023 to 2025), Rhythm Pharmaceuticals, Inc.'s net change in cash has grown at a -29.2% compound annual growth rate (CAGR), from -$73.62M to -$36.85M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.